Código QR (código de barras bidimensional)

Efficacy of nirsevimab for the prevention of RSV disease in infants: A systematic review, meta-analysis of randomized controlled trials, and global perspectives on recommendations and unmet needs

Background: Respiratory syncytial virus (RSV) is a major cause of infant hospitalizations, with limited prophylactic options historically available. Nirsevimab, a long-acting monoclonal antibody, has emerged as a promising agent for preventing RSV. Objective: To evaluate the efficacy and safety of n...

ver descrição completa

Na minha lista:
Principais autores: Hsin-Chweng Lien, Chi-Hone Lien, Tzu-Yu Liu, Shun-Long Weng, Yu-Lin Tai, Ya-Ning Huang, Hsin Chi, Nan-Chang Chiu, Chun-Yan Yeung, Chien-Yu Lin
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2026-05-01
coleção:Pediatrics and Neonatology
Assuntos:
Nirsevimab
Respiratory syncytial virus
RSV
Monoclonal antibody
Passive immunity
Beyfortus
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S1875957225002001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados